In addition, four of the other five MPE patients were positive, with single positivity for SHOX2 in ovarian and thymic squamous cell carcinoma and double positivity for SHOX2 and RASSF1A in lymphoma and adenoid cystic carcinoma. This evidence concerns the gene RASSF1 and thymus squamous cell carcinoma.